Overview

Antipsychotic Effects of Oxytocin

Status:
Terminated

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

The objective of the study is to compare the efficacy of intranasal oxytocin versus intranasal placebo to improve symptoms in schizophrenia patients who have residual symptoms despite being on adequate treatment with antipsychotic medication.

Phase:

N/A

Details

Lead Sponsor:

University of California, San Diego

Collaborator:

National Institute of Mental Health (NIMH)

Treatments:

Antipsychotic Agents
Oxytocin